Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov ID: NCT00087802

Public ClinicalTrials.gov record NCT00087802. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Trial of Gemcitabine/Oxaliplatin (GEMOX) Versus Carboplatin/Paclitaxel (CP) as First-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Study identification

NCT ID
NCT00087802
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
383 participants

Conditions and interventions

Interventions

  • carboplatin/paclitaxel (CP) Drug
  • gemcitabine/Eloxatin (GEMOX) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2004
Primary completion
Apr 30, 2007
Completion
Not listed
Last update posted
Apr 15, 2009

Started 2004

United States locations

U.S. sites
70
U.S. states
23
U.S. cities
65
Facility City State ZIP Site status
Birmingham Hematology and Oncology Associates, LLC Birmingham Alabama 35235
Birmingham Hematology and Oncology Associates Birmingham Alabama 35235
Hematology Oncology Associates Phoenix Arizona 85012
Northern Arizona Hematology & Oncology Associates Sedona Arizona 86336
Arizona Oncology Associates - Hematology Oncology Physicians Tucson Arizona 85704
Rocky Mountain Cancer Centers Denver Colorado 80218
Florida Cancer Institute New Port Richey Florida 34652
Ocala Oncology Center Ocala Florida 34474
Cancer Centers of Florida, P.A. Ocoee Florida 34761
South Florida Oncology & Hematology Consultants Plantation Florida 33324
Hematology Oncology Associates of Illinois Chicago Illinois 60611
Northwest Medical Specialists, PC Niles Illinois 60714
Hematology Oncology Associates of Illinois Skokie Illinois 60077
Central Indiana Cancer Centers Indianapolis Indiana 46227
Oncology Associates of Cedar Rapids Cedar Rapids Iowa 52403
Kansas City Oncology and Hematology Group Overland Park Kansas 66210
Maryland Oncology Hematology, P.A. Columbia Maryland 21044
Berkshire Hematology Oncology, PC Pittsfield Massachusetts 01201
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404
Minnesota Oncology Hematology Minneapolis Minnesota 55404
Missouri Cancer Associates Columbia Missouri 65201
Arch Medical Services, Inc. St Louis Missouri 63141
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89109
New Mexico Cancer Care Associates Santa Fe New Mexico 87505
New York Oncology Hematology, P.C. Albany New York 12208
New York Oncology Hematology Latham New York 12110
New York Oncology Hematology, P.C. Rexford New York 12148
Interlakes Oncology & Hematology, P.C. Rochester New York 14623
Raleigh Hematology Oncology Clinic Cary North Carolina 27511
Piedmont Hematology Oncology Associates, PLLC. Winston-Salem North Carolina 27103
Dayton Oncology & Hematology, P.A. Kettering Ohio 45409
Cancer Care Associates Oklahoma City Oklahoma 73120
Cancer Care Associates Tulsa Oklahoma 74136-1902
Willamette Valley Cancer Center Eugene Oregon 97401
Cancer Centers of the Carolinas Seneca South Carolina 29672
Texas Cancer Center - Abilene Abilene Texas 79606
Texas Oncology, P.A. Arlington Texas 76012
Texas Oncology Cancer Center Austin Texas 78731
Mamie McFaddin Ward Cancer Center Beaumont Texas 77702-1449
Texas Oncology, P.A. Bedford Texas 76022
Texas Cancer Center at Medical City Dallas Texas 75230-2510
Texas Oncology, P.A. Dallas Texas 75231
The Texas Cancer Center Dallas Texas 75237
Texas Oncology, P.A. Dallas Texas 75246
Texas Cancer Center - Denton Denton Texas 76210
El Paso Cancer Treatment Ctr-East El Paso Texas 79915
Texas Oncology, P.A. Fort Worth Texas 76104
San Antonio Tumor and Blood Clinic Fredericksburg Texas 78624
Texas Oncology, P.A. Garland Texas 75042-5788
Texas Oncology, P.A. Houston Texas 77024
Texas Oncology, P.A. Irving Texas 75061-2244
Lake Vista Cancer Center Lewisville Texas 75067
Longview Cancer Center Longview Texas 75601
South Texas Cancer Center - McAllen McAllen Texas 78503-1298
Texas Cancer Center of Mesquite Mesquite Texas 75150
Allison Cancer Center Midland Texas 79701-5946
West Texas Cancer Center Odessa Texas 79761
Paris Regional Cancer Center Paris Texas 75460
Hematology Oncology Associates of South Texas San Antonio Texas 78229
Texas Cancer Center - Sherman Sherman Texas 75090-0504
Tyler Cancer Center Tyler Texas 75702
Waco Cancer Care and Research Center Waco Texas 76712
Deke Slayton Cancer Center Webster Texas 77598
Fairfax Northern Virginia Hematology Oncology, PC Fairfax Virginia 22031
Virginia Oncology Associates Norfolk Virginia 23502
Oncology & Hematology Associates of Southwest Virginia, Inc. Salem Virginia 24153
Puget Sound Cancer Centers Edmonds Washington 98026
Puget Sound Cancer Centers Seattle Washington 98133
Cancer Care Northwest Spokane Washington 99218
Northwest Cancer Specialists, P.C. Vancouver Washington 98684

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00087802, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 15, 2009 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00087802 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →